

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitotic metaphase plate congression (GO:0007080) | 6.79834564 |
| 2 | purine nucleobase biosynthetic process (GO:0009113) | 5.72069290 |
| 3 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 5.36221081 |
| 4 | regulation of spindle organization (GO:0090224) | 5.27201161 |
| 5 | metaphase plate congression (GO:0051310) | 5.25263473 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.06721445 |
| 7 | DNA replication checkpoint (GO:0000076) | 5.02310161 |
| 8 | nucleobase biosynthetic process (GO:0046112) | 4.95018496 |
| 9 | ribosome biogenesis (GO:0042254) | 4.73994877 |
| 10 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.66018459 |
| 11 | termination of RNA polymerase III transcription (GO:0006386) | 4.66018459 |
| 12 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 4.59745222 |
| 13 | rRNA modification (GO:0000154) | 4.59545910 |
| 14 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.58430352 |
| 15 | negative regulation of ligase activity (GO:0051352) | 4.58430352 |
| 16 | protein localization to kinetochore (GO:0034501) | 4.55306270 |
| 17 | vitamin transmembrane transport (GO:0035461) | 4.51814728 |
| 18 | ribosome assembly (GO:0042255) | 4.40464076 |
| 19 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.35465809 |
| 20 | protein neddylation (GO:0045116) | 4.34326833 |
| 21 | establishment of chromosome localization (GO:0051303) | 4.33557108 |
| 22 | chaperone-mediated protein transport (GO:0072321) | 4.30180773 |
| 23 | ATP synthesis coupled proton transport (GO:0015986) | 4.29126055 |
| 24 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.29126055 |
| 25 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.28263145 |
| 26 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.24977651 |
| 27 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.24977651 |
| 28 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.24977651 |
| 29 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.24431807 |
| 30 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.24431807 |
| 31 | 7-methylguanosine mRNA capping (GO:0006370) | 4.24215521 |
| 32 | regulation of mitotic spindle organization (GO:0060236) | 4.18975764 |
| 33 | RNA capping (GO:0036260) | 4.18691591 |
| 34 | 7-methylguanosine RNA capping (GO:0009452) | 4.18691591 |
| 35 | maturation of 5.8S rRNA (GO:0000460) | 4.17303457 |
| 36 | protein localization to chromosome, centromeric region (GO:0071459) | 4.16291145 |
| 37 | positive regulation of chromosome segregation (GO:0051984) | 4.15436185 |
| 38 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.12258760 |
| 39 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.12258760 |
| 40 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 4.08848335 |
| 41 | cullin deneddylation (GO:0010388) | 4.07053423 |
| 42 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.06130263 |
| 43 | termination of RNA polymerase I transcription (GO:0006363) | 3.99123628 |
| 44 | protein deneddylation (GO:0000338) | 3.98738592 |
| 45 | folic acid metabolic process (GO:0046655) | 3.98401625 |
| 46 | transcription from RNA polymerase I promoter (GO:0006360) | 3.91598536 |
| 47 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.85263593 |
| 48 | CENP-A containing nucleosome assembly (GO:0034080) | 3.84012165 |
| 49 | establishment of integrated proviral latency (GO:0075713) | 3.80895503 |
| 50 | DNA deamination (GO:0045006) | 3.80664441 |
| 51 | rRNA methylation (GO:0031167) | 3.76893783 |
| 52 | respiratory electron transport chain (GO:0022904) | 3.76528840 |
| 53 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.74460074 |
| 54 | protein K6-linked ubiquitination (GO:0085020) | 3.73109623 |
| 55 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.70635408 |
| 56 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.69804641 |
| 57 | electron transport chain (GO:0022900) | 3.68677878 |
| 58 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.67372019 |
| 59 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.66412732 |
| 60 | meiosis I (GO:0007127) | 3.64733663 |
| 61 | spindle checkpoint (GO:0031577) | 3.63892532 |
| 62 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.61656331 |
| 63 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.61561738 |
| 64 | regulation of ligase activity (GO:0051340) | 3.58490345 |
| 65 | DNA-templated transcription, elongation (GO:0006354) | 3.58125023 |
| 66 | regulation of chromosome segregation (GO:0051983) | 3.58034554 |
| 67 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.57963178 |
| 68 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 3.57459564 |
| 69 | protein targeting to mitochondrion (GO:0006626) | 3.57149434 |
| 70 | establishment of viral latency (GO:0019043) | 3.56343224 |
| 71 | chromatin remodeling at centromere (GO:0031055) | 3.53792870 |
| 72 | folic acid transport (GO:0015884) | 3.53173287 |
| 73 | proteasome assembly (GO:0043248) | 3.52294503 |
| 74 | histone exchange (GO:0043486) | 3.51704771 |
| 75 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.51286730 |
| 76 | DNA replication-independent nucleosome organization (GO:0034724) | 3.51286730 |
| 77 | mitotic sister chromatid segregation (GO:0000070) | 3.46614499 |
| 78 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.45667062 |
| 79 | microtubule depolymerization (GO:0007019) | 3.41469762 |
| 80 | mitotic nuclear envelope disassembly (GO:0007077) | 3.41436598 |
| 81 | kinetochore assembly (GO:0051382) | 3.41077459 |
| 82 | blastocyst development (GO:0001824) | 3.41054142 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.40597864 |
| 84 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.39550492 |
| 85 | negative regulation of protein ubiquitination (GO:0031397) | 3.38291058 |
| 86 | rRNA processing (GO:0006364) | 3.37648750 |
| 87 | DNA replication initiation (GO:0006270) | 3.36364212 |
| 88 | inner cell mass cell proliferation (GO:0001833) | 3.35997351 |
| 89 | respiratory chain complex IV assembly (GO:0008535) | 3.34779370 |
| 90 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.32914778 |
| 91 | protein localization to chromosome (GO:0034502) | 3.31627918 |
| 92 | protein localization to mitochondrion (GO:0070585) | 3.31515087 |
| 93 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.30369695 |
| 94 | establishment of protein localization to mitochondrion (GO:0072655) | 3.30092675 |
| 95 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.30074524 |
| 96 | rRNA metabolic process (GO:0016072) | 3.29707723 |
| 97 | spliceosomal snRNP assembly (GO:0000387) | 3.28404354 |
| 98 | protein complex biogenesis (GO:0070271) | 3.28085199 |
| 99 | positive regulation of viral transcription (GO:0050434) | 3.26632789 |
| 100 | positive regulation of cell cycle arrest (GO:0071158) | 3.26106163 |
| 101 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.25023065 |
| 102 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.24953265 |
| 103 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.24953265 |
| 104 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.24061091 |
| 105 | regulation of cellular amine metabolic process (GO:0033238) | 3.22856631 |
| 106 | regulation of transcription from RNA polymerase I promoter (GO:0006356) | 3.22211649 |
| 107 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.21481344 |
| 108 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.21027297 |
| 109 | mitotic chromosome condensation (GO:0007076) | 3.20376896 |
| 110 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.19596840 |
| 111 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.19393043 |
| 112 | maturation of SSU-rRNA (GO:0030490) | 3.19300041 |
| 113 | mitotic spindle checkpoint (GO:0071174) | 3.17625661 |
| 114 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.16352133 |
| 115 | regulation of mitochondrial translation (GO:0070129) | 3.15451549 |
| 116 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.15147631 |
| 117 | membrane disassembly (GO:0030397) | 3.15008926 |
| 118 | nuclear envelope disassembly (GO:0051081) | 3.15008926 |
| 119 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.13710233 |
| 120 | regulation of translation in response to stress (GO:0043555) | 3.13575720 |
| 121 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.13401691 |
| 122 | NADH dehydrogenase complex assembly (GO:0010257) | 3.13401691 |
| 123 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.13401691 |
| 124 | oocyte maturation (GO:0001556) | 3.13275346 |
| 125 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.12812247 |
| 126 | formation of translation preinitiation complex (GO:0001731) | 3.11947381 |
| 127 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.11348534 |
| 128 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.11348534 |
| 129 | DNA strand elongation (GO:0022616) | 3.10173965 |
| 130 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.10058730 |
| 131 | meiotic chromosome segregation (GO:0045132) | 3.09898349 |
| 132 | chromosome segregation (GO:0007059) | 3.09138493 |
| 133 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.09071855 |
| 134 | male meiosis I (GO:0007141) | 3.07501785 |
| 135 | negative regulation of chromosome segregation (GO:0051985) | 3.07161519 |
| 136 | kinetochore organization (GO:0051383) | 3.04922282 |
| 137 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.04619018 |
| 138 | negative regulation of sister chromatid segregation (GO:0033046) | 3.04619018 |
| 139 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.04619018 |
| 140 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.04619018 |
| 141 | DNA-dependent DNA replication (GO:0006261) | 3.04548647 |
| 142 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.04431946 |
| 143 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.04315365 |
| 144 | positive regulation of ligase activity (GO:0051351) | 3.04222633 |
| 145 | transcription from mitochondrial promoter (GO:0006390) | 3.01328840 |
| 146 | pseudouridine synthesis (GO:0001522) | 2.98589575 |
| 147 | cytochrome complex assembly (GO:0017004) | 2.97505241 |
| 148 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.97497288 |
| 149 | mitotic spindle assembly checkpoint (GO:0007094) | 2.97167959 |
| 150 | DNA damage response, detection of DNA damage (GO:0042769) | 2.96187047 |
| 151 | transcription from RNA polymerase III promoter (GO:0006383) | 2.95922184 |
| 152 | spindle assembly checkpoint (GO:0071173) | 2.95542349 |
| 153 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.94726280 |
| 154 | cell cycle G1/S phase transition (GO:0044843) | 2.94726280 |
| 155 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.91965112 |
| 156 | protein-cofactor linkage (GO:0018065) | 2.90933423 |
| 157 | signal transduction in response to DNA damage (GO:0042770) | 2.90889154 |
| 158 | amino acid salvage (GO:0043102) | 2.90207984 |
| 159 | L-methionine salvage (GO:0071267) | 2.90207984 |
| 160 | L-methionine biosynthetic process (GO:0071265) | 2.90207984 |
| 161 | sequestering of actin monomers (GO:0042989) | 2.87620544 |
| 162 | histone mRNA metabolic process (GO:0008334) | 2.86798719 |
| 163 | peptidyl-histidine modification (GO:0018202) | 2.85170611 |
| 164 | IMP biosynthetic process (GO:0006188) | 2.78442650 |
| 165 | mitochondrial RNA metabolic process (GO:0000959) | 2.77991391 |
| 166 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.77742565 |
| 167 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.77381061 |
| 168 | inner mitochondrial membrane organization (GO:0007007) | 2.76852272 |
| 169 | DNA double-strand break processing (GO:0000729) | 2.74297022 |
| 170 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.73981386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.76377300 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.96460030 |
| 3 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.25612680 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.67995066 |
| 5 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.43737142 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.37868047 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.37761583 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.34064472 |
| 9 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.26286520 |
| 10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.21244498 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.14011682 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.10408521 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.81233960 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.66684518 |
| 15 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.60597795 |
| 16 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.56716532 |
| 17 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.51662178 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.46211521 |
| 19 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.41252380 |
| 20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.41216698 |
| 21 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.17845950 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.17712965 |
| 23 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.16629327 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.11241638 |
| 25 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.98306955 |
| 26 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.96788158 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.91150010 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.89912939 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.89667157 |
| 30 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.87083190 |
| 31 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.86760891 |
| 32 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.83644306 |
| 33 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.74982077 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.72223998 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.71924738 |
| 36 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.69892956 |
| 37 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.66401354 |
| 38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65185021 |
| 39 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63523842 |
| 40 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.61848117 |
| 41 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.61428821 |
| 42 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.60756304 |
| 43 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.53671463 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53571961 |
| 45 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.50188979 |
| 46 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.48933879 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.48035991 |
| 48 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.43457017 |
| 49 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.42470169 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.41746806 |
| 51 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.41228215 |
| 52 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.40824469 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.39265121 |
| 54 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.39051668 |
| 55 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.38447983 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36513048 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33965591 |
| 58 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32296899 |
| 59 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.29560048 |
| 60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28591740 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17630575 |
| 62 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17522575 |
| 63 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.17246360 |
| 64 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.13710959 |
| 65 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12082085 |
| 66 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.10119459 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09999344 |
| 68 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09516412 |
| 69 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08938619 |
| 70 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08650472 |
| 71 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08044745 |
| 72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06922363 |
| 73 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06744773 |
| 74 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.06543701 |
| 75 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.06292940 |
| 76 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.04425698 |
| 77 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.04203530 |
| 78 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02961102 |
| 79 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02706415 |
| 80 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02342892 |
| 81 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.00832819 |
| 82 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.97553993 |
| 83 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.97266689 |
| 84 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95877823 |
| 85 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.92750541 |
| 86 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92223318 |
| 87 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91995572 |
| 88 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.90052985 |
| 89 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.88135686 |
| 90 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.87824234 |
| 91 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.87560962 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86734834 |
| 93 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.86286797 |
| 94 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85124799 |
| 95 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.84953822 |
| 96 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84504914 |
| 97 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.81270228 |
| 98 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.80900832 |
| 99 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.80592054 |
| 100 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.79483399 |
| 101 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.78917280 |
| 102 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.77738996 |
| 103 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.77230373 |
| 104 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.76862909 |
| 105 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.75963931 |
| 106 | * MYC_22102868_ChIP-Seq_BL_Human | 0.75749259 |
| 107 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.75154801 |
| 108 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.74952914 |
| 109 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.73778450 |
| 110 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.72587303 |
| 111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72166221 |
| 112 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.71551229 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.71107104 |
| 114 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.70917259 |
| 115 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.70787027 |
| 116 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.68860531 |
| 117 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.68607864 |
| 118 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.67261774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 6.61253553 |
| 2 | MP0003111_abnormal_nucleus_morphology | 4.71434243 |
| 3 | MP0000372_irregular_coat_pigmentation | 4.36248377 |
| 4 | MP0003718_maternal_effect | 4.04220568 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 3.96724054 |
| 6 | MP0003077_abnormal_cell_cycle | 3.93441026 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.78367214 |
| 8 | MP0010094_abnormal_chromosome_stability | 3.71948029 |
| 9 | MP0008007_abnormal_cellular_replicative | 3.14811143 |
| 10 | MP0008057_abnormal_DNA_replication | 3.13763924 |
| 11 | MP0008058_abnormal_DNA_repair | 2.88672483 |
| 12 | MP0005451_abnormal_body_composition | 2.54137198 |
| 13 | MP0006035_abnormal_mitochondrial_morpho | 2.43809223 |
| 14 | MP0008260_abnormal_autophagy | 2.32165151 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.28522063 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 2.28466400 |
| 17 | MP0003123_paternal_imprinting | 2.28044057 |
| 18 | MP0008789_abnormal_olfactory_epithelium | 2.26546648 |
| 19 | MP0001730_embryonic_growth_arrest | 2.15002229 |
| 20 | MP0008932_abnormal_embryonic_tissue | 2.11930825 |
| 21 | MP0010307_abnormal_tumor_latency | 2.08628275 |
| 22 | MP0009697_abnormal_copulation | 2.04599695 |
| 23 | MP0008877_abnormal_DNA_methylation | 2.02171034 |
| 24 | MP0005075_abnormal_melanosome_morpholog | 1.96932513 |
| 25 | MP0003786_premature_aging | 1.96162965 |
| 26 | MP0000350_abnormal_cell_proliferation | 1.95377851 |
| 27 | MP0001529_abnormal_vocalization | 1.89074976 |
| 28 | MP0001545_abnormal_hematopoietic_system | 1.83120964 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 1.83120964 |
| 30 | MP0005394_taste/olfaction_phenotype | 1.83027199 |
| 31 | MP0005499_abnormal_olfactory_system | 1.83027199 |
| 32 | MP0003646_muscle_fatigue | 1.81096101 |
| 33 | MP0009840_abnormal_foam_cell | 1.74441619 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.72449389 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.64126147 |
| 36 | MP0005380_embryogenesis_phenotype | 1.60349878 |
| 37 | MP0001672_abnormal_embryogenesis/_devel | 1.60349878 |
| 38 | MP0002102_abnormal_ear_morphology | 1.49641227 |
| 39 | MP0002210_abnormal_sex_determination | 1.46104279 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.44363813 |
| 41 | MP0003221_abnormal_cardiomyocyte_apopto | 1.41405915 |
| 42 | MP0005395_other_phenotype | 1.38691446 |
| 43 | MP0003984_embryonic_growth_retardation | 1.38514291 |
| 44 | MP0001697_abnormal_embryo_size | 1.38057577 |
| 45 | MP0001929_abnormal_gametogenesis | 1.34544985 |
| 46 | MP0002088_abnormal_embryonic_growth/wei | 1.32586849 |
| 47 | MP0005671_abnormal_response_to | 1.31479938 |
| 48 | MP0002080_prenatal_lethality | 1.31424772 |
| 49 | MP0001661_extended_life_span | 1.30715055 |
| 50 | MP0003878_abnormal_ear_physiology | 1.29148299 |
| 51 | MP0005377_hearing/vestibular/ear_phenot | 1.29148299 |
| 52 | MP0002090_abnormal_vision | 1.26477818 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.24147453 |
| 54 | MP0000313_abnormal_cell_death | 1.22029663 |
| 55 | MP0001119_abnormal_female_reproductive | 1.21602740 |
| 56 | MP0000653_abnormal_sex_gland | 1.20443871 |
| 57 | MP0001145_abnormal_male_reproductive | 1.19867143 |
| 58 | MP0000516_abnormal_urinary_system | 1.19605338 |
| 59 | MP0005367_renal/urinary_system_phenotyp | 1.19605338 |
| 60 | MP0002095_abnormal_skin_pigmentation | 1.19376289 |
| 61 | MP0001293_anophthalmia | 1.18481390 |
| 62 | MP0003011_delayed_dark_adaptation | 1.17388547 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.17065525 |
| 64 | MP0003315_abnormal_perineum_morphology | 1.17033843 |
| 65 | MP0000015_abnormal_ear_pigmentation | 1.16595826 |
| 66 | MP0001853_heart_inflammation | 1.15613692 |
| 67 | MP0002132_abnormal_respiratory_system | 1.13839715 |
| 68 | MP0001324_abnormal_eye_pigmentation | 1.13621464 |
| 69 | MP0002938_white_spotting | 1.12240487 |
| 70 | MP0000490_abnormal_crypts_of | 1.12074692 |
| 71 | MP0000689_abnormal_spleen_morphology | 1.11293113 |
| 72 | MP0002398_abnormal_bone_marrow | 1.09205853 |
| 73 | MP0001542_abnormal_bone_strength | 1.08288066 |
| 74 | MP0002722_abnormal_immune_system | 1.07917999 |
| 75 | MP0005408_hypopigmentation | 1.05940667 |
| 76 | MP0000343_altered_response_to | 1.05863418 |
| 77 | MP0002085_abnormal_embryonic_tissue | 1.05684777 |
| 78 | MP0003136_yellow_coat_color | 1.02619518 |
| 79 | MP0003699_abnormal_female_reproductive | 1.02216287 |
| 80 | MP0003941_abnormal_skin_development | 1.02081449 |
| 81 | MP0005084_abnormal_gallbladder_morpholo | 1.01528310 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 1.01447703 |
| 83 | MP0005310_abnormal_salivary_gland | 1.01270000 |
| 84 | MP0005621_abnormal_cell_physiology | 1.00078137 |
| 85 | MP0009764_decreased_sensitivity_to | 0.98606638 |
| 86 | MP0000647_abnormal_sebaceous_gland | 0.97607674 |
| 87 | MP0000750_abnormal_muscle_regeneration | 0.94290976 |
| 88 | MP0005410_abnormal_fertilization | 0.91864524 |
| 89 | MP0005464_abnormal_platelet_physiology | 0.90318989 |
| 90 | MP0003938_abnormal_ear_development | 0.89339835 |
| 91 | MP0003763_abnormal_thymus_physiology | 0.88436989 |
| 92 | MP0002429_abnormal_blood_cell | 0.85982525 |
| 93 | MP0000716_abnormal_immune_system | 0.85411843 |
| 94 | MP0005384_cellular_phenotype | 0.85121750 |
| 95 | MP0000358_abnormal_cell_content/ | 0.84254736 |
| 96 | MP0003186_abnormal_redox_activity | 0.84084436 |
| 97 | MP0003828_pulmonary_edema | 0.83751085 |
| 98 | MP0002163_abnormal_gland_morphology | 0.83729805 |
| 99 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83683525 |
| 100 | MP0002084_abnormal_developmental_patter | 0.82519293 |
| 101 | MP0008995_early_reproductive_senescence | 0.82324332 |
| 102 | MP0002736_abnormal_nociception_after | 0.81886325 |
| 103 | MP0000703_abnormal_thymus_morphology | 0.81779852 |
| 104 | MP0005266_abnormal_metabolism | 0.79954196 |
| 105 | MP0005197_abnormal_uvea_morphology | 0.78934492 |
| 106 | MP0000627_abnormal_mammary_gland | 0.78789896 |
| 107 | MP0004147_increased_porphyrin_level | 0.78067601 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.77858453 |
| 109 | MP0002277_abnormal_respiratory_mucosa | 0.77503526 |
| 110 | MP0006082_CNS_inflammation | 0.76878305 |
| 111 | MP0002452_abnormal_antigen_presenting | 0.76151139 |
| 112 | MP0001919_abnormal_reproductive_system | 0.76105326 |
| 113 | MP0001835_abnormal_antigen_presentation | 0.75909438 |
| 114 | MP0002653_abnormal_ependyma_morphology | 0.74736690 |
| 115 | MP0001800_abnormal_humoral_immune | 0.74600625 |
| 116 | MP0001764_abnormal_homeostasis | 0.74147499 |
| 117 | MP0002420_abnormal_adaptive_immunity | 0.71812653 |
| 118 | MP0001819_abnormal_immune_cell | 0.71494282 |
| 119 | MP0005253_abnormal_eye_physiology | 0.71274248 |
| 120 | MP0000858_altered_metastatic_potential | 0.70786176 |
| 121 | MP0002723_abnormal_immune_serum | 0.69531379 |
| 122 | MP0008873_increased_physiological_sensi | 0.68628279 |
| 123 | MP0002161_abnormal_fertility/fecundity | 0.68045972 |
| 124 | MP0002160_abnormal_reproductive_system | 0.67979846 |
| 125 | MP0000371_diluted_coat_color | 0.67838987 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.67546125 |
| 127 | MP0002837_dystrophic_cardiac_calcinosis | 0.66399623 |
| 128 | MP0005058_abnormal_lysosome_morphology | 0.65667061 |
| 129 | MP0005083_abnormal_biliary_tract | 0.65527217 |
| 130 | MP0009046_muscle_twitch | 0.65450594 |
| 131 | MP0003195_calcinosis | 0.65288029 |
| 132 | MP0005389_reproductive_system_phenotype | 0.64620940 |
| 133 | MP0006036_abnormal_mitochondrial_physio | 0.64492949 |
| 134 | MP0010030_abnormal_orbit_morphology | 0.64440643 |
| 135 | MP0003937_abnormal_limbs/digits/tail_de | 0.63633763 |
| 136 | MP0005187_abnormal_penis_morphology | 0.62839008 |
| 137 | MP0003448_altered_tumor_morphology | 0.62775568 |
| 138 | MP0009763_increased_sensitivity_to | 0.62762000 |
| 139 | MP0009672_abnormal_birth_weight | 0.61948275 |
| 140 | MP0005332_abnormal_amino_acid | 0.61055184 |
| 141 | MP0002751_abnormal_autonomic_nervous | 0.59984237 |
| 142 | MP0003698_abnormal_male_reproductive | 0.59253821 |
| 143 | MP0001905_abnormal_dopamine_level | 0.59121537 |
| 144 | MP0005319_abnormal_enzyme/_coenzyme | 0.59094214 |
| 145 | MP0008469_abnormal_protein_level | 0.58077809 |
| 146 | MP0009785_altered_susceptibility_to | 0.57196868 |
| 147 | MP0002405_respiratory_system_inflammati | 0.56137500 |
| 148 | MP0001727_abnormal_embryo_implantation | 0.55386612 |
| 149 | MP0005000_abnormal_immune_tolerance | 0.54175699 |
| 150 | MP0009278_abnormal_bone_marrow | 0.53660393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 6.45846859 |
| 2 | Breast hypoplasia (HP:0003187) | 5.46270237 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 4.94866629 |
| 4 | Carpal bone hypoplasia (HP:0001498) | 4.86577708 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.69973944 |
| 6 | Acute encephalopathy (HP:0006846) | 4.50805556 |
| 7 | Mitochondrial inheritance (HP:0001427) | 4.38063316 |
| 8 | Patellar aplasia (HP:0006443) | 4.31341092 |
| 9 | Increased CSF lactate (HP:0002490) | 4.28691290 |
| 10 | Aplasia/Hypoplasia of the patella (HP:0006498) | 4.16615748 |
| 11 | Impulsivity (HP:0100710) | 4.11415117 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.95115980 |
| 13 | Hepatocellular necrosis (HP:0001404) | 3.88811283 |
| 14 | Cerebral hypomyelination (HP:0006808) | 3.82050380 |
| 15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.81813486 |
| 16 | Rough bone trabeculation (HP:0100670) | 3.76138880 |
| 17 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.75598757 |
| 18 | Hepatic necrosis (HP:0002605) | 3.75290568 |
| 19 | Hyperglycinemia (HP:0002154) | 3.72646722 |
| 20 | Renal Fanconi syndrome (HP:0001994) | 3.59907123 |
| 21 | Entropion (HP:0000621) | 3.54355024 |
| 22 | Chromsome breakage (HP:0040012) | 3.49139356 |
| 23 | Abnormal protein glycosylation (HP:0012346) | 3.45816102 |
| 24 | Abnormal glycosylation (HP:0012345) | 3.45816102 |
| 25 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.45816102 |
| 26 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.45816102 |
| 27 | Type I transferrin isoform profile (HP:0003642) | 3.42302461 |
| 28 | Lipid accumulation in hepatocytes (HP:0006561) | 3.42098520 |
| 29 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.33176804 |
| 30 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.30079509 |
| 31 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.30079509 |
| 32 | Multiple enchondromatosis (HP:0005701) | 3.29950811 |
| 33 | Cerebral edema (HP:0002181) | 3.25443588 |
| 34 | Increased serum lactate (HP:0002151) | 3.18457258 |
| 35 | Abnormality of the preputium (HP:0100587) | 3.17819612 |
| 36 | Meckel diverticulum (HP:0002245) | 3.16066794 |
| 37 | Facial hemangioma (HP:0000329) | 3.15996169 |
| 38 | Abnormality of glycolysis (HP:0004366) | 3.15434693 |
| 39 | Increased serum pyruvate (HP:0003542) | 3.13915422 |
| 40 | Irregular epiphyses (HP:0010582) | 3.12524268 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 3.11773714 |
| 42 | Increased intramyocellular lipid droplets (HP:0012240) | 3.10113471 |
| 43 | Capillary hemangiomas (HP:0005306) | 3.09321947 |
| 44 | Abnormal spermatogenesis (HP:0008669) | 3.09042055 |
| 45 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.02452278 |
| 46 | Secondary amenorrhea (HP:0000869) | 3.01720659 |
| 47 | Lactic acidosis (HP:0003128) | 3.01080622 |
| 48 | Pustule (HP:0200039) | 3.00745904 |
| 49 | Hyperglycinuria (HP:0003108) | 2.93757879 |
| 50 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.93488464 |
| 51 | Oral leukoplakia (HP:0002745) | 2.92596695 |
| 52 | Gout (HP:0001997) | 2.92111053 |
| 53 | Abnormality of the ileum (HP:0001549) | 2.88408136 |
| 54 | Reduced antithrombin III activity (HP:0001976) | 2.88003123 |
| 55 | Abnormal trabecular bone morphology (HP:0100671) | 2.79082355 |
| 56 | Microvesicular hepatic steatosis (HP:0001414) | 2.76840493 |
| 57 | Exercise intolerance (HP:0003546) | 2.76546864 |
| 58 | Flat capital femoral epiphysis (HP:0003370) | 2.75488666 |
| 59 | Abnormality of chromosome stability (HP:0003220) | 2.74081046 |
| 60 | Microretrognathia (HP:0000308) | 2.73585454 |
| 61 | Azoospermia (HP:0000027) | 2.71579180 |
| 62 | Respiratory failure (HP:0002878) | 2.71347727 |
| 63 | Abnormality of the labia minora (HP:0012880) | 2.65197494 |
| 64 | Nausea (HP:0002018) | 2.64015928 |
| 65 | CNS hypomyelination (HP:0003429) | 2.61051527 |
| 66 | Methylmalonic aciduria (HP:0012120) | 2.60388042 |
| 67 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.58866404 |
| 68 | Abnormal gallbladder physiology (HP:0012438) | 2.58157419 |
| 69 | Cholecystitis (HP:0001082) | 2.58157419 |
| 70 | Respiratory difficulties (HP:0002880) | 2.57659071 |
| 71 | Male infertility (HP:0003251) | 2.56839869 |
| 72 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.55266452 |
| 73 | Exertional dyspnea (HP:0002875) | 2.55243322 |
| 74 | Premature ovarian failure (HP:0008209) | 2.55012391 |
| 75 | Absent radius (HP:0003974) | 2.54014748 |
| 76 | Areflexia of lower limbs (HP:0002522) | 2.52995504 |
| 77 | Breast aplasia (HP:0100783) | 2.52961317 |
| 78 | Bone marrow hypocellularity (HP:0005528) | 2.51854494 |
| 79 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.50799206 |
| 80 | Type 2 muscle fiber atrophy (HP:0003554) | 2.48590193 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.48275599 |
| 82 | Progressive muscle weakness (HP:0003323) | 2.46586855 |
| 83 | Increased muscle lipid content (HP:0009058) | 2.45001671 |
| 84 | Muscle fiber atrophy (HP:0100295) | 2.44780162 |
| 85 | Prostate neoplasm (HP:0100787) | 2.44739866 |
| 86 | Ureteral duplication (HP:0000073) | 2.44003086 |
| 87 | Atrioventricular block (HP:0001678) | 2.42701764 |
| 88 | Aplastic anemia (HP:0001915) | 2.40274585 |
| 89 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 2.39161395 |
| 90 | Methylmalonic acidemia (HP:0002912) | 2.37526769 |
| 91 | Pancytopenia (HP:0001876) | 2.37044225 |
| 92 | Reticulocytopenia (HP:0001896) | 2.36236630 |
| 93 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.35832638 |
| 94 | Absent epiphyses (HP:0010577) | 2.35832638 |
| 95 | Death in infancy (HP:0001522) | 2.34499566 |
| 96 | Optic disc pallor (HP:0000543) | 2.33352476 |
| 97 | Aplasia involving forearm bones (HP:0009822) | 2.33004022 |
| 98 | Absent forearm bone (HP:0003953) | 2.33004022 |
| 99 | Myelodysplasia (HP:0002863) | 2.32044966 |
| 100 | CNS demyelination (HP:0007305) | 2.29623442 |
| 101 | Pancreatic fibrosis (HP:0100732) | 2.25845490 |
| 102 | Abnormality of methionine metabolism (HP:0010901) | 2.24526581 |
| 103 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.23620094 |
| 104 | Abnormality of alanine metabolism (HP:0010916) | 2.23620094 |
| 105 | Hyperalaninemia (HP:0003348) | 2.23620094 |
| 106 | Abnormality of renal resorption (HP:0011038) | 2.22741675 |
| 107 | Stillbirth (HP:0003826) | 2.22567385 |
| 108 | Sparse eyelashes (HP:0000653) | 2.21007166 |
| 109 | Lethargy (HP:0001254) | 2.20470157 |
| 110 | Small intestinal stenosis (HP:0012848) | 2.19695470 |
| 111 | Duodenal stenosis (HP:0100867) | 2.19695470 |
| 112 | Small epiphyses (HP:0010585) | 2.18936192 |
| 113 | Degeneration of anterior horn cells (HP:0002398) | 2.18025413 |
| 114 | Abnormality of the anterior horn cell (HP:0006802) | 2.18025413 |
| 115 | Leukodystrophy (HP:0002415) | 2.16956758 |
| 116 | IgG deficiency (HP:0004315) | 2.15396874 |
| 117 | Horseshoe kidney (HP:0000085) | 2.11726683 |
| 118 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.10937811 |
| 119 | Abnormality of glycine metabolism (HP:0010895) | 2.10937811 |
| 120 | Tetraplegia (HP:0002445) | 2.10103185 |
| 121 | Cleft eyelid (HP:0000625) | 2.07877048 |
| 122 | Sparse lateral eyebrow (HP:0005338) | 2.06979632 |
| 123 | Postnatal microcephaly (HP:0005484) | 2.04123768 |
| 124 | Petechiae (HP:0000967) | 2.03536533 |
| 125 | Oligodactyly (HP:0012165) | 2.03293153 |
| 126 | Mutism (HP:0002300) | 2.02662211 |
| 127 | Short thumb (HP:0009778) | 2.01404760 |
| 128 | Abnormality of the umbilical cord (HP:0010881) | 2.01372468 |
| 129 | Oligodactyly (hands) (HP:0001180) | 1.99402630 |
| 130 | Emotional lability (HP:0000712) | 1.99081013 |
| 131 | X-linked dominant inheritance (HP:0001423) | 1.98035499 |
| 132 | Poor head control (HP:0002421) | 1.97843935 |
| 133 | Delusions (HP:0000746) | 1.96149390 |
| 134 | Slender long bone (HP:0003100) | 1.94187904 |
| 135 | Premature graying of hair (HP:0002216) | 1.91583275 |
| 136 | Adrenal hypoplasia (HP:0000835) | 1.90771336 |
| 137 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.89800469 |
| 138 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.89452418 |
| 139 | Cellular immunodeficiency (HP:0005374) | 1.89440450 |
| 140 | Abnormal lung lobation (HP:0002101) | 1.88484057 |
| 141 | Abnormality of serum amino acid levels (HP:0003112) | 1.88288490 |
| 142 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.88251594 |
| 143 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.88164373 |
| 144 | Acute myeloid leukemia (HP:0004808) | 1.87691519 |
| 145 | Tracheoesophageal fistula (HP:0002575) | 1.85663398 |
| 146 | Squamous cell carcinoma (HP:0002860) | 1.85294595 |
| 147 | Clubbing of toes (HP:0100760) | 1.83497676 |
| 148 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.83485498 |
| 149 | Hypoplastic pelvis (HP:0008839) | 1.83152559 |
| 150 | Trismus (HP:0000211) | 1.82779966 |
| 151 | Absent thumb (HP:0009777) | 1.82427050 |
| 152 | Upper limb muscle weakness (HP:0003484) | 1.81756666 |
| 153 | Congenital, generalized hypertrichosis (HP:0004540) | 1.81558637 |
| 154 | Hypoplasia of the fovea (HP:0007750) | 1.81035712 |
| 155 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.81035712 |
| 156 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.79634861 |
| 157 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.78867837 |
| 158 | Neoplasm of the pancreas (HP:0002894) | 1.78861255 |
| 159 | Muscle fiber splitting (HP:0003555) | 1.77252638 |
| 160 | Abnormal number of erythroid precursors (HP:0012131) | 1.76409827 |
| 161 | Macrocytic anemia (HP:0001972) | 1.76031940 |
| 162 | Abnormality of placental membranes (HP:0011409) | 1.75500208 |
| 163 | Amniotic constriction ring (HP:0009775) | 1.75500208 |
| 164 | Prominent nose (HP:0000448) | 1.75328228 |
| 165 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.74392595 |
| 166 | Personality changes (HP:0000751) | 1.74381578 |
| 167 | Polycythemia (HP:0001901) | 1.74234683 |
| 168 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.73888948 |
| 169 | Dicarboxylic aciduria (HP:0003215) | 1.73888948 |
| 170 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.73851103 |
| 171 | Abnormality of the fovea (HP:0000493) | 1.71573436 |
| 172 | Abnormality of urine glucose concentration (HP:0011016) | 1.69105907 |
| 173 | Glycosuria (HP:0003076) | 1.69105907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.79676442 |
| 2 | WEE1 | 4.20512517 |
| 3 | BRSK2 | 3.40637701 |
| 4 | VRK2 | 3.35538067 |
| 5 | PLK4 | 3.30685663 |
| 6 | EIF2AK1 | 3.21523514 |
| 7 | SRPK1 | 3.04099340 |
| 8 | TRIM28 | 2.95770584 |
| 9 | NEK2 | 2.91452104 |
| 10 | NME2 | 2.80677165 |
| 11 | PBK | 2.80469872 |
| 12 | LATS2 | 2.30687871 |
| 13 | IRAK3 | 2.24623152 |
| 14 | ACVR1B | 2.18751064 |
| 15 | PLK1 | 2.12455556 |
| 16 | BRSK1 | 2.10987944 |
| 17 | PLK3 | 1.96528861 |
| 18 | TTK | 1.95749437 |
| 19 | CDC7 | 1.93320430 |
| 20 | EIF2AK3 | 1.84521157 |
| 21 | DYRK3 | 1.84175372 |
| 22 | MKNK2 | 1.74540067 |
| 23 | BCKDK | 1.74176824 |
| 24 | STK38L | 1.70646760 |
| 25 | MAP3K12 | 1.66305595 |
| 26 | MUSK | 1.59888309 |
| 27 | TESK2 | 1.58475346 |
| 28 | AURKB | 1.57921642 |
| 29 | ARAF | 1.57530296 |
| 30 | VRK1 | 1.53677537 |
| 31 | AKT3 | 1.51712786 |
| 32 | CCNB1 | 1.49637110 |
| 33 | RPS6KA4 | 1.47146049 |
| 34 | STK3 | 1.45316241 |
| 35 | MAP2K7 | 1.39840163 |
| 36 | CHEK2 | 1.36907566 |
| 37 | BRAF | 1.33912081 |
| 38 | ZAK | 1.33159273 |
| 39 | TSSK6 | 1.31602241 |
| 40 | STK16 | 1.28818722 |
| 41 | TAOK1 | 1.22999443 |
| 42 | MKNK1 | 1.19857211 |
| 43 | MAP4K2 | 1.16483750 |
| 44 | PIM2 | 1.15250109 |
| 45 | ADRBK2 | 1.11843799 |
| 46 | RAF1 | 1.11292943 |
| 47 | DAPK1 | 1.09474786 |
| 48 | NEK1 | 1.09092827 |
| 49 | AURKA | 1.09033775 |
| 50 | MARK3 | 1.01330306 |
| 51 | STK24 | 0.96847081 |
| 52 | MAP3K8 | 0.96676195 |
| 53 | CDK7 | 0.96651131 |
| 54 | WNK3 | 0.95608994 |
| 55 | PIM1 | 0.93527111 |
| 56 | CDK4 | 0.89396717 |
| 57 | CHEK1 | 0.85403613 |
| 58 | BMPR1B | 0.85046728 |
| 59 | DYRK2 | 0.84513438 |
| 60 | STK4 | 0.82261457 |
| 61 | PAK4 | 0.81934496 |
| 62 | LIMK1 | 0.81837418 |
| 63 | ABL2 | 0.81237329 |
| 64 | ERBB3 | 0.80984067 |
| 65 | MAP2K3 | 0.79570983 |
| 66 | MELK | 0.78127671 |
| 67 | CDK3 | 0.77555101 |
| 68 | MAP4K1 | 0.77126155 |
| 69 | BCR | 0.76702076 |
| 70 | TESK1 | 0.76701664 |
| 71 | PAK1 | 0.76452989 |
| 72 | EIF2AK2 | 0.75580499 |
| 73 | PLK2 | 0.73715709 |
| 74 | PINK1 | 0.72806334 |
| 75 | PDK2 | 0.71202219 |
| 76 | CSNK1G2 | 0.71047905 |
| 77 | SIK3 | 0.70159608 |
| 78 | STK10 | 0.70003598 |
| 79 | EPHA2 | 0.69745502 |
| 80 | PRKCI | 0.69708153 |
| 81 | CSNK1A1L | 0.67223687 |
| 82 | NUAK1 | 0.66239254 |
| 83 | CDK8 | 0.64846638 |
| 84 | ILK | 0.64215376 |
| 85 | ATR | 0.62725100 |
| 86 | GRK7 | 0.62591709 |
| 87 | MAP3K6 | 0.62081997 |
| 88 | BMPR2 | 0.61831858 |
| 89 | DAPK3 | 0.61570202 |
| 90 | MAP3K3 | 0.61337413 |
| 91 | ZAP70 | 0.60942794 |
| 92 | LATS1 | 0.59583235 |
| 93 | MAP3K11 | 0.58633534 |
| 94 | MATK | 0.55551835 |
| 95 | MAP3K5 | 0.54059523 |
| 96 | TAOK2 | 0.52527233 |
| 97 | CDK2 | 0.52284349 |
| 98 | GRK1 | 0.51792116 |
| 99 | KDR | 0.49197936 |
| 100 | PDK4 | 0.48782620 |
| 101 | PDK3 | 0.48782620 |
| 102 | IKBKB | 0.44740627 |
| 103 | RPS6KB2 | 0.44537826 |
| 104 | CSNK2A1 | 0.43490079 |
| 105 | ATM | 0.43470787 |
| 106 | TLK1 | 0.42801489 |
| 107 | ERBB4 | 0.41619226 |
| 108 | PRKAA1 | 0.41362530 |
| 109 | MYLK | 0.38862406 |
| 110 | MAPKAPK3 | 0.38576911 |
| 111 | TXK | 0.37878850 |
| 112 | CDK1 | 0.37105173 |
| 113 | KSR2 | 0.36790036 |
| 114 | JAK3 | 0.35986233 |
| 115 | NEK6 | 0.35769891 |
| 116 | TAOK3 | 0.35458796 |
| 117 | TYK2 | 0.34835801 |
| 118 | TBK1 | 0.33354025 |
| 119 | IRAK4 | 0.32397129 |
| 120 | MAP3K4 | 0.32373905 |
| 121 | NEK9 | 0.31842095 |
| 122 | CSNK1G3 | 0.30432528 |
| 123 | CSNK2A2 | 0.30407600 |
| 124 | PASK | 0.30268092 |
| 125 | GRK5 | 0.30209918 |
| 126 | EEF2K | 0.30170648 |
| 127 | RPS6KA5 | 0.30000233 |
| 128 | CDK14 | 0.29739968 |
| 129 | CDK19 | 0.28999356 |
| 130 | FER | 0.27293995 |
| 131 | PRKCG | 0.26094295 |
| 132 | TEC | 0.25468499 |
| 133 | CSNK1G1 | 0.23510686 |
| 134 | MOS | 0.22740885 |
| 135 | NME1 | 0.21108686 |
| 136 | MST4 | 0.19858269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.55343321 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 5.34190417 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 4.29473359 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.44882043 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.20400375 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.09042331 |
| 7 | RNA transport_Homo sapiens_hsa03013 | 3.06208623 |
| 8 | Cell cycle_Homo sapiens_hsa04110 | 3.05834148 |
| 9 | Basal transcription factors_Homo sapiens_hsa03022 | 2.85255769 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.73210936 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.72060126 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.47873958 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 2.39727360 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 2.11493350 |
| 15 | p53 signaling pathway_Homo sapiens_hsa04115 | 2.10788182 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 2.09858036 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.07962965 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.06414654 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.97114083 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.90902878 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.87896939 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.84409215 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.84190860 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.83375094 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.80425288 |
| 26 | Purine metabolism_Homo sapiens_hsa00230 | 1.75595386 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.73182744 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.67787886 |
| 29 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.65622678 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50667939 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.44300813 |
| 32 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.41993965 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.38515631 |
| 34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.32432252 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24765387 |
| 36 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.23245110 |
| 37 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.22034315 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19286310 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17252006 |
| 40 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.15625899 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.10010079 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09809831 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08584829 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07062501 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06557571 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05982626 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.05817838 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.02400934 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99830212 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98237238 |
| 51 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.93996928 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92539993 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89028034 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87624522 |
| 55 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83447276 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81661034 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.79678519 |
| 58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.75920135 |
| 59 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.74970399 |
| 60 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.74160708 |
| 61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.74160408 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70834226 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69339624 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65662503 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63998220 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 0.63117856 |
| 67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61114824 |
| 68 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60934503 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58938045 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57194867 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56829325 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56509660 |
| 73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55493738 |
| 74 | Protein export_Homo sapiens_hsa03060 | 0.54500731 |
| 75 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52021449 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50626960 |
| 77 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48125507 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48038420 |
| 79 | Huntingtons disease_Homo sapiens_hsa05016 | 0.47567236 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43591007 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42659174 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42254577 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.42048319 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41701497 |
| 85 | Apoptosis_Homo sapiens_hsa04210 | 0.40550230 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40104194 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39466099 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.35983015 |
| 89 | Influenza A_Homo sapiens_hsa05164 | 0.35781775 |
| 90 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35714293 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35553275 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35480399 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33945473 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33148600 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.31447124 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31235738 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30851170 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30010456 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.28476089 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.27569000 |
| 101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27465127 |
| 102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26866817 |
| 103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26639592 |
| 104 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.26582187 |
| 105 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26144542 |
| 106 | Carbon metabolism_Homo sapiens_hsa01200 | 0.26098128 |
| 107 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.26089495 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.24601054 |
| 109 | Allograft rejection_Homo sapiens_hsa05330 | 0.24150046 |
| 110 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.23717173 |
| 111 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.23456435 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.23097932 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.22788116 |
| 114 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.22035382 |
| 115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.21786308 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.21385183 |
| 117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.21064152 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.20675730 |
| 119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.15540503 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.15523285 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.15416437 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.15123284 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.14952482 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.14809920 |
| 125 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.14088526 |
| 126 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.13799142 |
| 127 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.11831299 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.11669213 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.10771334 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.10474768 |
| 131 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.09226171 |
| 132 | Leishmaniasis_Homo sapiens_hsa05140 | 0.08299651 |
| 133 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.07549803 |
| 134 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.06322716 |
| 135 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.06162040 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.06111175 |
| 137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.05305832 |
| 138 | Asthma_Homo sapiens_hsa05310 | 0.05105331 |

